{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T03:04:04Z","timestamp":1793243044352,"version":"4.5.0"},"reference-count":247,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ejmech.2024.116170","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T16:39:29Z","timestamp":1706805569000},"page":"116170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["pH regulators and their inhibitors in tumor microenvironment"],"prefix":"10.1016","volume":"267","author":[{"given":"Senyi","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhizhong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyong","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangping","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9673-4727","authenticated-orcid":false,"given":"Guotao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.116170_bib1","first-page":"57","article-title":"Targeting tumor microenvironment by small-molecule inhibitors, Transl","volume":"13","author":"Zhong","year":"2020","journal-title":"Oncol."},{"key":"10.1016\/j.ejmech.2024.116170_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.110216","article-title":"From Warburg effect to Reverse Warburg effect; the new horizons of anticancer therapy","volume":"144","author":"Benny","year":"2020","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.ejmech.2024.116170_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.semcancer.2016.12.003","article-title":"Value of pH regulators in the diagnosis, prognosis and treatment of cancer","volume":"43","author":"Granja","year":"2017","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ejmech.2024.116170_bib4","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.humimm.2022.01.014","article-title":"The acidic tumour microenvironment: manipulating the immune response to elicit escape","volume":"83","author":"Worsley","year":"2022","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.ejmech.2024.116170_bib5","doi-asserted-by":"crossref","first-page":"8363","DOI":"10.3390\/ijms21218363","article-title":"Lactic acid and an acidic tumor microenvironment suppress anticancer immunity","volume":"21","author":"Wang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2024.116170_bib6","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.cmet.2018.08.006","article-title":"Increased lactate secretion by cancer cells sustains non-cell-autonomous adaptive resistance to MET and EGFR targeted therapies","volume":"28","author":"Apicella","year":"2018","journal-title":"Cell Metabol."},{"key":"10.1016\/j.ejmech.2024.116170_bib7","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1158\/2159-8290.CD-21-0925","article-title":"A targetable myeloid inflammatory state governs disease recurrence in clear-cell renal cell carcinoma","volume":"12","author":"Rappold","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ejmech.2024.116170_bib8","doi-asserted-by":"crossref","first-page":"11828","DOI":"10.1074\/jbc.M213243200","article-title":"Mutations of Arg440 and Gly455\/Gly456 oppositely change pH sensing of Na+\/H+ exchanger 1","volume":"278","author":"Wakabayashi","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3390\/metabo7030048","article-title":"Carbonic anhydrase inhibition and the management of hypoxic tumors","volume":"7","author":"Supuran","year":"2017","journal-title":"Metabolites"},{"key":"10.1016\/j.ejmech.2024.116170_bib10","doi-asserted-by":"crossref","first-page":"83088","DOI":"10.18632\/oncotarget.20236","article-title":"Overexpression of carbonic anhydrase IX induces cell motility by activating matrix metalloproteinase-9 in human oral squamous cell carcinoma cells","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2024.116170_bib11","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.mam.2012.05.003","article-title":"The SLC16 gene family \u2013 structure, role and regulation in health and disease","volume":"34","author":"Halestrap","year":"2013","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.ejmech.2024.116170_bib12","first-page":"E49","article-title":"The Prognostic significance of the expression of monocarboxylate transporter 4 in patients with right- or left-sided colorectal Cancer, Asia-Pac","volume":"15","author":"Abe","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2024.116170_bib13","first-page":"4278","article-title":"Monocarboxylate transporter 4 (MCT4) overexpression is correlated with poor prognosis of osteosarcoma","volume":"25","author":"Liu","year":"2019","journal-title":"Med. Sci. Mon. Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.ejmech.2024.116170_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165894","article-title":"Targeting lactate production and efflux in prostate cancer","volume":"1866","author":"Pereira-Nunes","year":"2020","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."},{"key":"10.1016\/j.ejmech.2024.116170_bib15","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/MPA.0000000000001369","article-title":"Expression of monocarboxylate transporter 1 is associated with better prognosis and reduced nodal metastasis in pancreatic ductal adenocarcinoma","volume":"48","author":"Sukeda","year":"2019","journal-title":"Pancreas"},{"key":"10.1016\/j.ejmech.2024.116170_bib16","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.3892\/ol.2020.11776","article-title":"Prognostic and predictive value of monocarboxylate transporter 4 in patients with breast cancer","volume":"20","author":"Xiao","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ejmech.2024.116170_bib17","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1080\/15384101.2016.1188239","article-title":"Prognostic significance of monocarboxylate transporter expression in oral cavity tumors","volume":"15","author":"Simoes-Sousa","year":"2016","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ejmech.2024.116170_bib18","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1186\/s12885-015-1842-4","article-title":"Reprogramming energy metabolism and inducing angiogenesis: co-expression of monocarboxylate transporters with VEGF family members in cervical adenocarcinomas","volume":"15","author":"Pinheiro","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejmech.2024.116170_bib19","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3390\/ijms18040170","article-title":"Evaluation of MCT1, MCT4 and CD147 ggenes in peripheral blood cells of breast cancer patients and their potential use as diagnostic and prognostic markers","volume":"18","author":"Luz","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2024.116170_bib20","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.bbrc.2018.05.091","article-title":"Monocarboxylate transporters in breast cancer and adipose tissue are novel biomarkers and potential therapeutic targets","volume":"501","author":"Li","year":"2018","journal-title":"Biochem Bioph Res Co"},{"key":"10.1016\/j.ejmech.2024.116170_bib21","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3389\/fonc.2018.00324","article-title":"Monocarboxylate transporter 4 (MCT4) knockout mice have attenuated 4NQO induced carcinogenesis; a role for MCT4 in driving oral squamous cell cancer","volume":"8","author":"Bisetto","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejmech.2024.116170_bib22","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.molmet.2019.07.006","article-title":"Monocarboxylate transporters in cancer","volume":"33","author":"Payen","year":"2020","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.ejmech.2024.116170_bib23","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.tibs.2020.07.005","article-title":"SLC16 family: from atomic structure to human disease","volume":"46","author":"Bosshart","year":"2021","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ejmech.2024.116170_bib24","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1093\/emboj\/19.15.3896","article-title":"CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression","volume":"19","author":"Kirk","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmech.2024.116170_bib25","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1167\/iovs.02-0552","article-title":"Loss of MCT1, MCT3, and MCT4 expression in the retinal pigment epithelium and neural retina of the 5A11\/basigin-null mouse","volume":"44","author":"Philp","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejmech.2024.116170_bib26","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.cell.2020.11.043","article-title":"Structural basis of human monocarboxylate transporter 1 inhibition by anti-cancer drug candidates","volume":"184","author":"Wang","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2024.116170_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101454","article-title":"Lactate as a fulcrum of metabolism","volume":"35","author":"Brooks","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejmech.2024.116170_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.107451","article-title":"Lactate\/GPR81 signaling and proton motive force in cancer: role in angiogenesis, immune escape, nutrition, and Warburg phenomenon","volume":"206","author":"Brown","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2024.116170_bib29","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.tibs.2018.10.011","article-title":"Lactate: a metabolic driver in the tumour landscape","volume":"44","author":"Ippolito","year":"2019","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ejmech.2024.116170_bib30","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/08830185.2021.1955876","article-title":"Lactic acid in macrophage polarization: the significant role in inflammation and cancer","volume":"41","author":"Zhou","year":"2022","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.ejmech.2024.116170_bib31","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1152\/physiol.00016.2017","article-title":"Lactic acid: no longer an inert and end-product of glycolysis","volume":"32","author":"Sun","year":"2017","journal-title":"Physiology"},{"key":"10.1016\/j.ejmech.2024.116170_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112393","article-title":"Monocarboxylate transporter 1 and 4 inhibitors as potential therapeutics for treating solid tumours: a review with structure-activity relationship insights","volume":"199","author":"Puri","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.semcancer.2014.01.005","article-title":"Catabolic cancer-associated fibroblasts transfer energy and biomass to anabolic cancer cells, fueling tumor growth","volume":"25","author":"Martinez-Outschoorn","year":"2014","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ejmech.2024.116170_bib34","doi-asserted-by":"crossref","first-page":"23111","DOI":"10.1074\/jbc.M202487200","article-title":"Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis","volume":"277","author":"Lu","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib35","doi-asserted-by":"crossref","first-page":"41928","DOI":"10.1074\/jbc.M508718200","article-title":"Reversible inactivation of HIF-1 prolyl hydroxylases allows cell metabolism to control basal HIF-1","volume":"280","author":"Lu","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib36","doi-asserted-by":"crossref","first-page":"18154","DOI":"10.1073\/pnas.0602235103","article-title":"Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NF\u03baB activity","volume":"103","author":"Cummins","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2024.116170_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033418","article-title":"Targeting the lactate transporter MCT1 in endothelial cells inhibits lactate-induced HIF-1 activation and tumor angiogenesis","volume":"7","author":"Sonveaux","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2024.116170_bib38","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1002\/mc.22707","article-title":"Monocarboxylate transporter 1 is a key player in glioma-endothelial cell crosstalk","volume":"56","author":"Miranda-Goncalves","year":"2017","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.ejmech.2024.116170_bib39","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.canlet.2019.04.002","article-title":"Cancer-associated fibroblasts-derived IL-8 mediates resistance to cisplatin in human gastric cancer","volume":"454","author":"Zhai","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejmech.2024.116170_bib40","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.molmet.2019.07.006","article-title":"Monocarboxylate transporters in cancer","volume":"33","author":"Payen","year":"2020","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.ejmech.2024.116170_bib41","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1042\/bj1380313","article-title":"Specific inhibition of pyruvate transport in rat liver mitochondria and human erythrocytes by \u03b1-cyano-4-hydroxycinnamate","volume":"138","author":"Halestrap","year":"1974","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2024.116170_bib42","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1016\/j.bbamcr.2016.03.013","article-title":"Monocarboxylate transporters in the brain and in cancer","volume":"1863","author":"P\u00e9rez-Escuredo","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2024.116170_bib43","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1021\/acsmedchemlett.5b00049","article-title":"Monocarboxylate transporter 1 inhibitors as potential anticancer agents","volume":"6","author":"Gurrapu","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.116170_bib44","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.18632\/oncotarget.26760","article-title":"Novel N,N-dialkyl cyanocinnamic acids as monocarboxylate transporter 1 and 4 inhibitors","volume":"10","author":"Jonnalagadda","year":"2019","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2024.116170_bib45","series-title":"Novel Alpha Cyanocinnamate Derivatives as Monocarboxylate Transporter-1 Inhibitors","author":"Connell","year":"2011"},{"key":"10.1016\/j.ejmech.2024.116170_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-54709-7","article-title":"Development of novel silyl cyanocinnamic acid derivatives as metabolic plasticity inhibitors for cancer treatment","volume":"9","author":"Nelson","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2024.116170_bib47","series-title":"Synthesis and Evaluation of Indole Cyanoacrylic Acids as Anticancer","author":"Samuel","year":"2016"},{"key":"10.1016\/j.ejmech.2024.116170_bib48","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1021\/acs.jmedchem.2c01612","article-title":"Indole derivatives as new structural class of potent and antiproliferative inhibitors of monocarboxylate transporter 1 (MCT1; SLC16A1)","volume":"66","author":"Puri","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib49","doi-asserted-by":"crossref","first-page":"7107","DOI":"10.1016\/j.bmc.2013.09.010","article-title":"Synthesis and pharmacological evaluation of carboxycoumarins as a new antitumor treatment targeting lactate transport in cancer cells","volume":"21","author":"Draoui","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib50","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1158\/1535-7163.MCT-13-0653","article-title":"Antitumor activity of 7-aminocarboxycoumarin derivatives, a new class of potent inhibitors of lactate influx but not efflux","volume":"13","author":"Draoui","year":"2014","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.ejmech.2024.116170_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115870","article-title":"Synthesis and anticancer activity of new coumarin-3-carboxylic acid derivatives as potential lactatetransportinhibitors","volume":"29","author":"Ji","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib52","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1124\/jpet.102.044412","article-title":"Effects of the flavonoids biochanin A, morin, phloretin, and silymarin on P-Glycoprotein-Mediated transport","volume":"304","author":"Zhang","year":"2003","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2024.116170_bib53","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1124\/dmd.105.005926","article-title":"Flavonoids as a novel class of human organic anion-transporting polypeptide OATP1B1 (OATP-C) modulators","volume":"33","author":"Wang","year":"2005","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejmech.2024.116170_bib54","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00018-002-8424-8","article-title":"Modulation by flavonoids of cell multidrug resistance mediated by P-glycoprotein and related ABC transporters","volume":"59","author":"Pietro","year":"2002","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejmech.2024.116170_bib55","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1124\/dmd.105.007872","article-title":"Effects of herbal extracts on the function of human organic anion-transporting polypeptide OATP-B","volume":"34","author":"Fuchikami","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejmech.2024.116170_bib56","doi-asserted-by":"crossref","first-page":"4852","DOI":"10.1158\/0008-5472.CAN-04-1817","article-title":"Flavonoid structure-activity studies identify 6-prenylchrysin and tectochrysin as potent and specific inhibitors of breast cancer resistance protein ABCG2","volume":"65","author":"Ahmed-Belkacem","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2024.116170_bib57","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/j.lfs.2005.12.003","article-title":"Flavonoid\u2013drug interactions: effects of flavonoids on ABC transporters","volume":"78","author":"Morris","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2024.116170_bib58","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1021\/bi00583a011","article-title":"Inhibition of lactate transport and glycolysis in ehrlich ascites tumor cells by bioflavonoids","volume":"18","author":"Belt","year":"1979","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2024.116170_bib59","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1124\/jpet.106.105965","article-title":"Transport of gamma-hydroxybutyrate in rat kidney membrane vesicles: role of monocarboxylate transporters","volume":"318","author":"Wang","year":"2006","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2024.116170_bib60","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1124\/dmd.106.012369","article-title":"Flavonoids modulate monocarboxylate transporter-1-mediated transport of gamma-hydroxybutyrate in vitro and in vivo","volume":"35","author":"Wang","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejmech.2024.116170_bib61","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1158\/1535-7163.MCT-17-1253","article-title":"Preclinical efficacy of the novel monocarboxylate transporter 1 inhibitor BAY-8002 and associated markers of resistance","volume":"17","author":"Quanz","year":"2018","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.ejmech.2024.116170_bib62","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nchembio744","article-title":"Monocarboxylate transporter MCT1 is a target for immunosuppression","volume":"1","author":"Murray","year":"2005","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2024.116170_bib63","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1016\/j.bmcl.2006.01.024","article-title":"Potent blockers of the monocarboxylate transporter MCT1: novel immunomodulatory compounds","volume":"16","author":"Guile","year":"2006","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2024.116170_bib64","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1021\/jm060995h","article-title":"Optimization of monocarboxylate transporter 1 blockers through analysis and modulation of atropisomer interconversion properties","volume":"50","author":"Guile","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib65","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1042\/BJ20091515","article-title":"AR-C155858 is a potent inhibitor of monocarboxylate transporters MCT1 and MCT2 that binds to an intracellular site involving transmembrane helices 7-10","volume":"425","author":"Ovens","year":"2010","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2024.116170_bib66","doi-asserted-by":"crossref","first-page":"7317","DOI":"10.1021\/jm500640x","article-title":"Synthesis and structure activity relationships of pteridine dione and trione monocarboxylate transporter 1 inhibitors","volume":"57","author":"Wang","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib67","unstructured":"B.T. D., W. Hui, W. Chao, C.J. L., Chromenone inhibitors of monocarboxylate transporters, in, The Scripps Research Institute, (United States)."},{"key":"10.1016\/j.ejmech.2024.116170_bib68","unstructured":"K.M. Parnell, J. McCall, D. Romero, Heterocyclic Inhibitors of MCT4, in, Vettore, LLC, (United States)."},{"key":"10.1016\/j.ejmech.2024.116170_bib69","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.bbrc.2017.10.025","article-title":"Identification of a selective inhibitor of human monocarboxylate transporter 4","volume":"495","author":"Futagi","year":"2018","journal-title":"Biochem Bioph Res Co"},{"key":"10.1016\/j.ejmech.2024.116170_bib70","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1021\/acs.jmedchem.2c01342","article-title":"Discovery of clinical candidate AZD0095, a selective inhibitor of monocarboxylate transporter 4 (MCT4) for oncology","volume":"66","author":"Goldberg","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib71","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.2174\/1389201019666180308091504","article-title":"Effects of a series of acidic drugs on L-lactic acid transport by the monocarboxylate transporters MCT1 and MCT4","volume":"18","author":"Leung","year":"2017","journal-title":"Curr. Pharmaceut. Biotechnol."},{"key":"10.1016\/j.ejmech.2024.116170_bib72","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.dmpk.2016.03.004","article-title":"Effect of diclofenac on SLC16A3\/MCT4 by the Caco-2 cell line","volume":"31","author":"Sasaki","year":"2016","journal-title":"Drug Metabol. Pharmacokinet."},{"key":"10.1016\/j.ejmech.2024.116170_bib73","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.celrep.2019.08.068","article-title":"Restricting glycolysis preserves T cell effector functions and augments checkpoint therapy","volume":"29","author":"Renner","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejmech.2024.116170_bib74","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1601756","article-title":"Syrosingopine sensitizes cancer cells to killing by metformin","volume":"2","author":"Benjamin","year":"2016","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejmech.2024.116170_bib75","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1016\/j.celrep.2018.11.043","article-title":"Dual inhibition of the lactate transporters MCT1 and MCT4 Is synthetic lethal with metformin due to NAD+ depletion in cancer cells","volume":"25","author":"Benjamin","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejmech.2024.116170_bib76","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1469-7793.2000.00285.x","article-title":"Characterisation of human monocarboxylate transporter 4 substantiates its role in lactic acid efflux from skeletal muscle","volume":"529","author":"Fox","year":"2000","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejmech.2024.116170_bib77","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1042\/bj3040751","article-title":"The Kinetics, substrate and inhibitor specificity of the lactate transporter of Ehrlich-Lettre tumour cells studied with the intracellular pH indicator BCECF","volume":"304","author":"Carpenter","year":"1994","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2024.116170_bib78","doi-asserted-by":"crossref","first-page":"27213","DOI":"10.1074\/jbc.M411950200","article-title":"Basigin (CD147) is the target for organomercurial inhibition of monocarboxylate transporter isoforms 1 and 4: the ancillary protein for the insensitive MCT2 is EMBIGIN (gp70)","volume":"280","author":"Wilson","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.115206","article-title":"Paris Saponin II-induced saraptosis-associated cell death increased the sensitivity of cisplatin","volume":"406","author":"Man","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116170_bib80","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cbi.2016.05.016","article-title":"Paris Saponin II induced apoptosis via activation of autophagy in human lung cancer cells","volume":"253","author":"Zhang","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2024.116170_bib81","doi-asserted-by":"crossref","first-page":"682","DOI":"10.3390\/antiox9080682","article-title":"Saponin Formosanin C-induced ferritinophagy and ferroptosis in human hepatocellular carcinoma cells","volume":"9","author":"Lin","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejmech.2024.116170_bib82","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.3892\/or.2015.3836","article-title":"Paris saponin II inhibits human ovarian cancer cell-induced angiogenesis by modulating NF-\u03baB signaling","volume":"33","author":"Yang","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ejmech.2024.116170_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154618","article-title":"Formosanin C inhibits non-small-cell lung cancer progression by blocking MCT4\/CD147-mediated lactate export","volume":"109","author":"Li","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejmech.2024.116170_bib84","first-page":"1373","article-title":"Substrate balances across colonic carcinomas in humans","volume":"55","author":"Holm","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2024.116170_bib85","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2174\/138161208783877884","article-title":"Carbonic anhydrases \u2013 an overview","volume":"14","author":"Supuran","year":"2008","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejmech.2024.116170_bib86","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1177\/002215549804600409","article-title":"Immunohistochemistry of carbonic anhydrase isozyme IX (MN\/CA IX) in human gut reveals polarized expression in the epithelial cells with the highest proliferative capacity","volume":"46","author":"Saarnio","year":"1998","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.ejmech.2024.116170_bib87","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.urology.2009.09.052","article-title":"Quantification of carbonic anhydrase IX expression in serum and tissue of renal cell carcinoma patients using enzyme-linked Immunosorbent assay: prognostic and diagnostic potentials","volume":"75","author":"Zhou","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.ejmech.2024.116170_bib88","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114096","article-title":"Prognostic value of carbonic anhydrase IX immunohistochemical expression in renal cell carcinoma: a meta-analysis of the literature","volume":"9","author":"Zhao","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2024.116170_bib89","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s12253-017-0284-5","article-title":"Overexpression of FZD1 and CAIX are associated with invasion, metastasis, and poor-prognosis of the pancreatic ductal adenocarcinoma","volume":"24","author":"Yang","year":"2018","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.ejmech.2024.116170_bib90","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.3390\/cancers12082005","article-title":"Clinical and pre-clinical evidence of carbonic anhydrase IX in pancreatic cancer and its high expression in pre-cancerous lesions","volume":"12","author":"Strapcova","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ejmech.2024.116170_bib91","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/1471-2407-11-167","article-title":"Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1 alpha, CAIX, LDH-5, GLUT-1, MCT1 and MCT4","volume":"11","author":"Rademakers","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejmech.2024.116170_bib92","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/jop.12721","article-title":"PAI-1, CAIX, and VEGFA expressions as prognosis markers in oral squamous cell carcinoma","volume":"47","author":"Peterle","year":"2018","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.ejmech.2024.116170_bib93","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/his.12341","article-title":"Paxillin and carbonic anhydrase IX are prognostic markers in gallbladder squamous cell\/adenosquamous carcinomas and adenocarcinomas","volume":"64","author":"Liu","year":"2014","journal-title":"Histopathology"},{"key":"10.1016\/j.ejmech.2024.116170_bib94","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0002-9440(10)64038-2","article-title":"Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer","volume":"158","author":"Ivanov","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejmech.2024.116170_bib95","doi-asserted-by":"crossref","first-page":"15789","DOI":"10.1074\/jbc.M110.188524","article-title":"Catalysis and pH control by membrane-associated carbonic anhydrase IX in MDA-MB-231 breast cancer cells","volume":"286","author":"Li","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib96","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/nature07017","article-title":"Magnetic resonance imaging of pH in vivo using hyperpolarized 13C-labelled bicarbonate","volume":"453","author":"Gallagher","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2024.116170_bib97","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.1073\/pnas.92.12.5510","article-title":"Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension","volume":"92","author":"Wang","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2024.116170_bib98","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3389\/fphys.2013.00271","article-title":"The effect of carbonic anhydrase IX on focal contacts during cell spreading and migration","volume":"4","author":"Csaderova","year":"2013","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ejmech.2024.116170_bib99","doi-asserted-by":"crossref","first-page":"5825","DOI":"10.1016\/j.bmcl.2009.08.088","article-title":"The proteoglycan region of the tumor-associated carbonic anhydrase isoform IX acts as anintrinsic buffer optimizing CO2 hydration at acidic pH values characteristic of solid tumors","volume":"19","author":"Innocenti","year":"2009","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2024.116170_bib100","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.3390\/cancers12061616","article-title":"How and why are cancers acidic? carbonic anhydrase IX and the homeostatic control of tumour extracellular pH","volume":"12","author":"Lee","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ejmech.2024.116170_bib101","doi-asserted-by":"crossref","first-page":"27940","DOI":"10.18632\/oncotarget.25371","article-title":"The proteoglycan-like domain of carbonic anhydrase IX mediates non-catalytic facilitation of lactate transport in cancer cells","volume":"9","author":"Ames","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2024.116170_bib102","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1021\/ja809683v","article-title":"Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors","volume":"131","author":"Maresca","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2024.116170_bib103","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41416-019-0642-z","article-title":"Carbonic anhydrase IX and acid transport in cancer","volume":"122","author":"Becker","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejmech.2024.116170_bib104","doi-asserted-by":"crossref","first-page":"47886","DOI":"10.1074\/jbc.M105959200","article-title":"A transport metabolon. Functional interaction of carbonic anhydrase II and chloride\/bicarbonate exchangers","volume":"276","author":"Sterling","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib105","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1113\/jphysiol.2002.029777","article-title":"Regulation of the sodium bicarbonate cotransporter kNBC1 function: role of Asp(986), Asp(988) and kNBC1-carbonic anhydrase II binding","volume":"544","author":"Gross","year":"2002","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejmech.2024.116170_bib106","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/0968768031000122520","article-title":"Structural and functional characterization of the human NBC3 sodium\/bicarbonate co-transporter carboxyl-terminal cytoplasmic domain","volume":"20","author":"Loiselle","year":"2003","journal-title":"Mol. Membr. Biol."},{"key":"10.1016\/j.ejmech.2024.116170_bib107","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1152\/ajpcell.00157.2007","article-title":"Interactions of transmembrane carbonic anhydrase, CAIX, with bicarbonate transporters","volume":"293","author":"Morgan","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.ejmech.2024.116170_bib108","doi-asserted-by":"crossref","DOI":"10.1038\/srep13605","article-title":"Hypoxia-induced carbonic anhydrase IX facilitates lactate flux in human breast cancer cells by non-catalytic function","volume":"5","author":"Jamali","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2024.116170_bib109","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1038\/s41388-019-1098-6","article-title":"CAIX forms a transport metabolon with monocarboxylate transporters in human breast cancer cells","volume":"39","author":"Ames","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2024.116170_bib110","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.35176","article-title":"A surface proton antenna in carbonic anhydrase II supports lactate transport in cancer cells","volume":"7","author":"Noor","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.ejmech.2024.116170_bib111","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2024.116170_bib112","doi-asserted-by":"crossref","first-page":"8371","DOI":"10.1039\/c0cc02707c","article-title":"Selective hydrophobic pocket binding observed within the carbonic anhydrase II active site accommodate different 4-substituted-ureido-benzenesulfonamides and correlate to inhibitor potency","volume":"46","author":"Pacchiano","year":"2010","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2024.116170_bib113","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1021\/jm101541x","article-title":"Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis","volume":"54","author":"Pacchiano","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib114","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1016\/j.bmc.2017.03.027","article-title":"Synthesis and carbonic anhydrase inhibition of a series of SLC-0111 analogs","volume":"25","author":"Carta","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib115","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1021\/jm300529u","article-title":"Antimetastatic effect of sulfamate carbonic anhydrase IX inhibitors in breast carcinoma xenografts","volume":"55","author":"Gieling","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib116","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1016\/j.bmc.2009.03.066","article-title":"Synthesis and evaluation of pharmacological profile of 1-aryl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamides","volume":"17","author":"Gitto","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib117","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1021\/jm2000213","article-title":"Structural basis for the interaction between carbonic anhydrase and 1,2,3,4-tetrahydroisoquinolin-2-ylsulfonamides","volume":"54","author":"Mader","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib118","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1021\/jm9014026","article-title":"Identification of 3,4-dihydroisoquinoline-2(1H)-sulfonamides as potent carbonic anhydrase inhibitors: synthesis, biological evaluation, and enzyme--ligand X-ray studies","volume":"53","author":"Gitto","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib119","doi-asserted-by":"crossref","first-page":"13760","DOI":"10.1002\/anie.201307583","article-title":"Carborane-based carbonic anhydrase inhibitors","volume":"52","author":"Brynda","year":"2013","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2024.116170_bib120","doi-asserted-by":"crossref","first-page":"9560","DOI":"10.1021\/acs.jmedchem.9b00945","article-title":"Metallacarborane sulfamides: unconventional, specific, and highly selective inhibitors of carbonic anhydrase IX","volume":"62","author":"Gruner","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib121","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/cplu.202000574","article-title":"Cobalt bis(dicarbollide) alkylsulfonamides: potent and highly selective inhibitors of tumor specific carbonic anhydrase IX","volume":"86","author":"Gruner","year":"2021","journal-title":"Chempluschem"},{"key":"10.1016\/j.ejmech.2024.116170_bib122","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0223-5234(96)85163-4","article-title":"Carbonic anhydrase inhibitors. Part 35. Synthesis of cchiff bases derived from sulfanilamide and aromatic aldehydes: the first inhibitors with equally high affinity towards cytosolic and membrane-bound isozymes","volume":"31","author":"Supuran","year":"1996","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib123","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/14756360410001689595","article-title":"Carbonic anhydrase inhibitors: schiff's bases of aromatic and heterocyclic sulfonamides and their metal complexes","volume":"19","author":"Mahmood Ul","year":"2004","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib124","doi-asserted-by":"crossref","first-page":"6493","DOI":"10.1039\/C5OB00688K","article-title":"Discovery of novel isatin-based sulfonamides with potent and selective inhibition of the tumor-associated carbonic anhydrase isoforms IX and XII","volume":"13","author":"Guzel-Akdemir","year":"2015","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib125","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejmech.2018.07.054","article-title":"Novel hydrazido benzenesulfonamides-isatin conjugates: synthesis, carbonic anhydrase inhibitory activity and molecular modeling studies","volume":"157","author":"Abo-Ashour","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib126","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ejmech.2017.01.017","article-title":"Novel indolin-2-one-based sulfonamides as carbonic anhydrase inhibitors: synthesis, in vitro biological evaluation against carbonic anhydrases isoforms I, II, IV and VII and molecular docking studies","volume":"127","author":"Eldehna","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib127","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ejmech.2016.01.030","article-title":"Amido\/ureidosubstituted benzenesulfonamides-isatin conjugates as low nanomolar\/subnanomolar inhibitors of the tumor-associated carbonic anhydrase isoform XII","volume":"110","author":"Eldehna","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib128","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ejmech.2015.09.021","article-title":"Isatin-pyrazole benzenesulfonamide hybrids potently inhibit tumor-associated carbonic anhydrase isoforms IX and XII","volume":"103","author":"Ibrahim","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103514","article-title":"Synthesis and selective inhibitory effects of some 2-oxindole benzenesulfonamide conjugates on human carbonic anhydrase isoforms CA I, CA II, CA IX and CAXII","volume":"95","author":"George","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103754","article-title":"Synthesis and SAR studies of novel 1,2,4-oxadiazole-sulfonamide based compounds as potential anticancer agents for colorectal cancer therapy","volume":"98","author":"Shamsi","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib131","doi-asserted-by":"crossref","first-page":"7697","DOI":"10.1002\/anie.200701189","article-title":"Saccharin inhibits carbonic anhydrases: possible explanation for its unpleasant metallic aftertaste","volume":"46","author":"Kohler","year":"2007","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2024.116170_bib132","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1021\/jm500255y","article-title":"Cyclic secondary sulfonamides: unusually good inhibitors of cancer-related carbonic anhydrase enzymes","volume":"57","author":"Moeker","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib133","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.bmc.2014.01.056","article-title":"Design, synthesis and evaluation of N-substituted saccharin derivatives as selective inhibitors of tumor-associated carbonic anhydrase XII","volume":"22","author":"D'Ascenzio","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib134","doi-asserted-by":"crossref","first-page":"6547","DOI":"10.1021\/acs.jmedchem.6b00616","article-title":"1,2-Benzisothiazole derivatives bearing 4-, 5-, or 6-alkyl\/arylcarboxamide moieties inhibit carbonic anhydrase isoform IX (CAIX) and cell proliferation under hypoxic conditions","volume":"59","author":"Coviello","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib135","doi-asserted-by":"crossref","first-page":"7875","DOI":"10.1021\/jm300981b","article-title":"Carbamoylphosphonates control tumor cell proliferation and dissemination by simultaneously inhibiting carbonic anhydrase IX and matrix metalloproteinase-2. Toward nontoxic chemotherapy targeting tumor microenvironment","volume":"55","author":"Reich","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib136","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1021\/jm701087n","article-title":"Carbamoylphosphonate matrix metalloproteinase inhibitors 6: cis-2-aminocyclohexylcarbamoylphosphonic acid, a novel orally active antimetastatic matrix metalloproteinase-2 selective inhibitor\u2014synthesis and pharmacodynamic and pharmacokinetic analysis","volume":"51","author":"Hoffman","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib137","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1158\/1078-0432.CCR-04-1985","article-title":"Carbamoylphosphonate matrix metalloproteinase inhibitors 3: in vivo evaluation of cyclopentylcarbamoylphosphonic acid in experimental metastasis and angiogenesis","volume":"11","author":"Reich","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2024.116170_bib138","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1021\/jm030386z","article-title":"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids","volume":"47","author":"Breuer","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib139","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1016\/j.tetasy.2004.07.002","article-title":"Carbamoylphosphonate MMP inhibitors. Part 4: the influence of chirality and geometrical isomerism on the potency and selectivity of inhibition","volume":"15","author":"Breuer","year":"2004","journal-title":"Tetrahedron: Asymmetry"},{"key":"10.1016\/j.ejmech.2024.116170_bib140","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00775-004-0524-5","article-title":"Carbamoylphosphonate-based matrix metalloproteinase inhibitor metal complexes: solution studies and stability constants. Towards a zinc-selective binding group","volume":"9","author":"Farkas","year":"2004","journal-title":"J. Biol. Inorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib141","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/hc.21256","article-title":"Synthesis of enantiomeric aminoalkylcarbamoylphosphonates and their evaluation as dual-action anticancer MMP and carbonic anhydrase inhibitors","volume":"26","author":"Veerendhar","year":"2015","journal-title":"Heteroat. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib142","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.bmcl.2004.11.058","article-title":"Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic\/tumor-associated carbonic anhydrase isozymes I, II, and IX with bis-sulfamates","volume":"15","author":"Winum","year":"2005","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2024.116170_bib143","doi-asserted-by":"crossref","first-page":"26249","DOI":"10.3390\/ijms161125953","article-title":"Betulinyl sulfamates as anticancer agents and radiosensitizers in human breast cancer cells","volume":"16","author":"Bache","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2024.116170_bib144","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cbi.2018.02.014","article-title":"Synthesis and biological investigation of new carbonic anhydrase IX (CAIX) inhibitors","volume":"284","author":"Vanchanagiri","year":"2018","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2024.116170_bib145","doi-asserted-by":"crossref","first-page":"5703","DOI":"10.1021\/acs.jmedchem.3c00007","article-title":"Atropo\/tropo flexibility: a tool for design and synthesis of self-adaptable inhibitors of carbonic anhydrases and their antiproliferative effect","volume":"66","author":"Ivanova","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib146","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/1087057108315739","article-title":"Direct screening of natural product extracts using mass spectrometry","volume":"13","author":"Vu","year":"2008","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.ejmech.2024.116170_bib147","doi-asserted-by":"crossref","first-page":"7255","DOI":"10.1016\/j.bmcl.2010.10.094","article-title":"7,8-Disubstituted- but not 6,7-disubstituted coumarins selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II in the low nanomolar\/subnanomolar range","volume":"20","author":"Maresca","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2024.116170_bib148","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1016\/j.bmcl.2010.06.040","article-title":"Coumarins incorporating hydroxy- and chloro-moieties selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II","volume":"20","author":"Maresca","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2024.116170_bib149","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1021\/jm901287j","article-title":"Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins","volume":"53","author":"Maresca","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib150","doi-asserted-by":"crossref","first-page":"8271","DOI":"10.1021\/jm200983e","article-title":"Glycosyl coumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors","volume":"54","author":"Touisni","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib151","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1016\/j.bmc.2012.02.014","article-title":"Novel coumarins and 2-thioxo-coumarins as inhibitors of the tumor-associated carbonic anhydrases IX and XII","volume":"20","author":"Carta","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib152","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3109\/14756366.2013.777334","article-title":"Novel coumarins and benzocoumarins acting as isoform-selective inhibitors against the tumor-associated carbonic anhydrase IX","volume":"29","author":"Sharma","year":"2014","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib153","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.3109\/14756366.2015.1113173","article-title":"Synthesis and carbonic anhydrase inhibitory properties of amino acid - coumarin\/quinolinone conjugates incorporating glycine, alanine and phenylalanine moieties","volume":"31","author":"Kucukbay","year":"2016","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib154","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejmech.2018.01.033","article-title":"Structural investigations on coumarins leading to chromeno 4,3-c pyrazol-4-ones and pyrano 4,3-c pyrazol-4-ones: new scaffolds for the design of the tumor-associated carbonic anhydrase isoforms IX and XII","volume":"146","author":"Bonardi","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib155","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ejmech.2017.11.061","article-title":"Inhibitory effects and structural insights for a novel series of coumarin-based compounds that selectively target human CA IX and CA XII carbonic anhydrases","volume":"143","author":"De Luca","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib156","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.3390\/ijms20051208","article-title":"Novel 8-substituted coumarins that selectively inhibit human carbonic anhydrase IX and XII","volume":"20","author":"Buran","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2024.116170_bib157","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.127877","article-title":"Synthesis and biological evaluation of novel 4,7-disubstituted coumarins as selective tumor-associated carbonic anhydrase IX and XII inhibitors","volume":"39","author":"Chandra","year":"2021","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2024.116170_bib158","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1016\/j.bmc.2010.06.028","article-title":"Coumarinyl-substituted sulfonamides strongly inhibit several human carbonic anhydrase isoforms: solution and crystallographic investigations","volume":"18","author":"Wagner","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib159","doi-asserted-by":"crossref","first-page":"9152","DOI":"10.1021\/jm501314c","article-title":"Structural insights on carbonic anhydrase inhibitory action, isoform selectivity, and potency of sulfonamides and coumarins incorporating arylsulfonylureido groups","volume":"57","author":"Bozdag","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib160","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1016\/j.bmc.2015.09.041","article-title":"Click-tailed coumarins with potent and selective inhibitory action against the tumor-associated carbonic anhydrases IX and XII","volume":"23","author":"Nocentini","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib161","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1016\/j.bmc.2016.04.052","article-title":"Novel sulfonamide bearing coumarin scaffolds as selective inhibitors of tumor associated carbonic anhydrase isoforms IX and XII","volume":"24","author":"Chandak","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib162","article-title":"Synthesis of coumarin-sulfonamide derivatives and determination of their cytotoxicity, carbonic anhydrase inhibitory and molecular docking studies","volume":"183","author":"Kurt","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib163","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112897","article-title":"Novel 3-substituted coumarins as selective human carbonic anhydrase IX and XII inhibitors: synthesis, biological and molecular dynamics analysis","volume":"209","author":"Abdelrahman","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib164","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105888","article-title":"Insights into the effect of elaborating coumarin-based aryl enaminones with sulfonamide or carboxylic acid functionality on carbonic anhydrase inhibitory potency and selectivity","volume":"126","author":"Ibrahim","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib165","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.bmcl.2011.11.018","article-title":"5-and 6-Membered (thio)lactones are prodrug type carbonic anhydrase inhibitors","volume":"22","author":"Carta","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2024.116170_bib166","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.bmc.2015.02.023","article-title":"Synthesis of 6-aryl-substituted sulfocoumarins and investigation of their carbonic anhydrase inhibitory action","volume":"23","author":"Grandane","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib167","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3109\/14756366.2014.970185","article-title":"7-Amino-3,4-dihydro-1H-quinolin-2-one, a compound similar to the substituted coumarins, inhibits alpha-carbonic anhydrases without hydrolysis of the lactam ring","volume":"30","author":"Vullo","year":"2015","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib168","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1021\/acs.jmedchem.5b01720","article-title":"Thioxocoumarins show an alternative carbonic anhydrase inhibition mechanism compared to coumarins","volume":"59","author":"Ferraroni","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib169","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/cmdc.201700446","article-title":"Sulfocoumarin-, coumarin-, 4-sulfamoylphenyl-bearing indazole-3-carboxamide hybrids: synthesis and selective inhibition of tumor-associated carbonic anhydrase isozymes IX and XII","volume":"12","author":"Angapelly","year":"2017","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2024.116170_bib170","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1080\/14756366.2017.1316720","article-title":"3H-1,2-benzoxathiepine 2,2-dioxides: a new class of isoform-selective carbonic anhydrase inhibitors","volume":"32","author":"Pustenko","year":"2017","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib171","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1021\/acsmedchemlett.8b00362","article-title":"Heterocoumarins are selective carbonic anhydrase IX and XII Inhibitors with cytotoxic effects against cancer cells lines","volume":"9","author":"Angeli","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.116170_bib172","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115586","article-title":"New coumarin\/sulfocoumarin linked phenylacrylamides as selective transmembrane carbonic anhydrase inhibitors: synthesis and in-vitro biological evaluation","volume":"28","author":"Swain","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib173","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1080\/14756366.2022.2041630","article-title":"Isocoumarins: a new class of selective carbonic anhydrase IX and XII inhibitors","volume":"37","author":"Onyilmaz","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib174","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.bmc.2012.07.021","article-title":"Natural product coumarins that inhibit human carbonic anhydrases","volume":"21","author":"Davis","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib175","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1080\/14756366.2020.1713114","article-title":"Coumarins from Magydaris pastinacea as inhibitors of the tumour-associated carbonic anhydrases IX and XII: isolation, biological studies and in silico evaluation","volume":"35","author":"Fois","year":"2020","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib176","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1080\/14756366.2020.1786821","article-title":"Synthesis, computational studies and assessment ofin vitroinhibitory activity of umbelliferon-based compounds against tumour-associated carbonic anhydrase isoforms IX and XII","volume":"35","author":"Mancuso","year":"2020","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib177","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1080\/14756366.2021.1887171","article-title":"Selective inhibition of carbonic anhydrase IX and XII by coumarin and psoralen derivatives","volume":"36","author":"Meleddu","year":"2021","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib178","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3109\/14756366.2011.650692","article-title":"Metronidazole-coumarin conjugates and 3-cyano-7-hydroxy-coumarin act as isoform-selective carbonic anhydrase inhibitors","volume":"28","author":"Bonneau","year":"2013","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib179","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.bioorg.2019.03.003","article-title":"Synthesis, biological activity and multiscale molecular modeling studies of bis-coumarins as selective carbonic anhydrase IX and XII inhibitors with effective cytotoxicity against hepatocellular carcinoma","volume":"87","author":"Kurt","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib180","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.bioorg.2019.04.004","article-title":"Synthesis and biological evaluation of coumarin-1,3,4-oxadiazole hybrids as selective carbonic anhydrase IX and XII inhibitors","volume":"87","author":"Narella","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib181","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1080\/14756366.2020.1822829","article-title":"Toxicity evaluation of sulfamides and coumarins that efficiently inhibit human carbonic anhydrases","volume":"35","author":"Aspatwar","year":"2020","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib182","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104272","article-title":"Synthesis and biological evaluation of some coumarin hybrids as selective carbonic anhydrase IX and XII inhibitors","volume":"104","author":"Thacker","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib183","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.3390\/cryst11091076","article-title":"Synthesis, crystal structure, inhibitory activity and molecular docking of coumarins\/sulfonamides containing triazolyl pyridine moiety as potent selective carbonic anhydrase IX and XII inhibitors","volume":"11","author":"Aimene","year":"2021","journal-title":"Crystals"},{"key":"10.1016\/j.ejmech.2024.116170_bib184","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1002\/cmdc.202000915","article-title":"Coumarin-thiourea hybrids show potent carbonic anhydrase IX and XIII inhibitory action","volume":"16","author":"Thacker","year":"2021","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2024.116170_bib185","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3390\/metabo11040225","article-title":"Synthesis and biological evaluation of coumarin-linked 4-anilinomethyl-1,2,3-triazoles as potent inhibitors of carbonic anhydrases IX and XIII Involved in tumorigenesis","volume":"11","author":"Thacker","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.ejmech.2024.116170_bib186","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/14756366.2021.2024528","article-title":"Discovery of 2,4-thiazolidinedione-tethered coumarins as novel selective inhibitors for carbonic anhydrase IX and XII isoforms","volume":"37","author":"Eldehna","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib187","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1080\/14756366.2021.1998026","article-title":"2-Aminobenzoxazole-appended coumarins as potent and selective inhibitors of tumour-associated carbonic anhydrases","volume":"37","author":"Fuentes-Aguilar","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib188","doi-asserted-by":"crossref","DOI":"10.1002\/ejoc.202101538","article-title":"Carbonic anhydrase inhibitors featuring a porphyrin scaffold: synthesis, optical and biological properties","volume":"2022","author":"Merabti","year":"2022","journal-title":"Eur. J. Org Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib189","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1080\/14756366.2022.2056734","article-title":"Novel 3-(6-methylpyridin-2-yl)coumarin-based chalcones as selective inhibitors of cancer-related carbonic anhydrases IX and XII endowed with anti-proliferative activity","volume":"37","author":"Tawfik","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib190","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ejmech.2017.12.049","article-title":"Design, synthesis and biological evaluation of novel pyridine-thiazolidinone derivatives as anticancer agents: targeting human carbonic anhydrase IX","volume":"144","author":"Ansari","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib191","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.128966","article-title":"Novel adamantane-pyrazole and hydrazone hybridized: design, synthesis, cytotoxic evaluation, SAR study and molecular docking simulation as carbonic anhydrase inhibitors","volume":"1223","author":"Wassel","year":"2021","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2024.116170_bib192","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2174\/2211352514666160606115200","article-title":"Biological activities and in silico physico-chemical properties of 1,2,3- triazoles derived from natural bioactive alcohols","volume":"14","author":"Irfan","year":"2016","journal-title":"Anti-Infective Agents"},{"key":"10.1016\/j.ejmech.2024.116170_bib193","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1021\/acsmedchemlett.9b00023","article-title":"\u03b1,\u03b3-Diketocarboxylic acids and their esters act as carbonic anhydrase IX and XII selective inhibitors","volume":"10","author":"Nocentini","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.116170_bib194","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115424","article-title":"Design, synthesis & biological evaluation of ferulic acid-based small molecule inhibitors against tumor-associated carbonic anhydrase IX","volume":"28","author":"Aneja","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib195","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3892\/ol.2021.12534","article-title":"Advances in research on the regulatory mechanism of NHE1 in tumors","volume":"21","author":"Hu","year":"2021","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ejmech.2024.116170_bib196","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1152\/ajpregu.00782.2005","article-title":"Physiology and pathophysiology of Na+\/H+ exchange and Na+ -K+ -2Cl- cotransport in the heart, brain, and blood","volume":"291","author":"Pedersen","year":"2006","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.ejmech.2024.116170_bib197","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.ejcb.2012.04.004","article-title":"pH regulators in invadosomal functioning: proton delivery for matrix tasting","volume":"91","author":"Brisson","year":"2012","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.ejmech.2024.116170_bib198","first-page":"85","article-title":"Na+-H+ exchanger, pH regulation and cancer, Recent Pat","volume":"8","author":"Reshkin","year":"2013","journal-title":"Anti Cancer Drug Des."},{"key":"10.1016\/j.ejmech.2024.116170_bib199","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0223-5234(03)00100-4","article-title":"An overview of inhibitors of Na+\/H+ exchanger","volume":"38","author":"Masereel","year":"2003","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib200","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0006-291X(05)80232-3","article-title":"Estimation of carrier density and turnover rate of the Na+\/H+ exchanger in human platelets using 5-(N-methyl-N-[3H]Isobutyl)amiloride","volume":"176","author":"Rosskopf","year":"1991","journal-title":"Biochem Bioph Res Co"},{"key":"10.1016\/j.ejmech.2024.116170_bib201","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1016\/S0021-9258(18)61399-7","article-title":"Estimation of the number and turnover rate of Na+\/H+ sxchangers in lymphocytes. Effect of phorbol ester and osmotic shrinking","volume":"262","author":"Dixon","year":"1987","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib202","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1016\/S0021-9258(18)61399-7","article-title":"Estimation of the number and turnover rate of Na+\/H+ exchangers in lymphocytes. Effect of phorbol ester and osmotic shrinking","volume":"262","author":"Dixon","year":"1987","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib203","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.3390\/ijms22062999","article-title":"Screening of 5- and 6-substituted amiloride libraries identifies dual-uPA\/NHE1 active and single target-selective inhibitors","volume":"22","author":"Buckley","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2024.116170_bib204","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/S0968-0896(02)00022-6","article-title":"Synthesis and biological evaluation of aroylguanidines related to amiloride as inhibitors of the human platelet Na+\/H+ exchanger","volume":"10","author":"Laeckmann","year":"2002","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib205","unstructured":"E.H. Christian, L. Hans-Jochen, L. Wolfgang, S. Bernward, S. Wolfgang, Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament, in, Hoechst AG, (Germany)."},{"key":"10.1016\/j.ejmech.2024.116170_bib206","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0008-6363(96)88579-8","article-title":"Protective effects of HOE642, a selective sodium-hydrogen exchange subtype 1 Inhibitor, on cardiac ischaemia and reperfusion","volume":"29","author":"Scholz","year":"1995","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejmech.2024.116170_bib207","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1476-5381.1993.tb13607.x","article-title":"HOE 694, a new Na+\/H+ exchange inhibitor and its effects in cardiac ischaemia","volume":"109","author":"Scholz","year":"1993","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116170_bib208","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1021\/jm960768n","article-title":"(2-methyl-5-(methylsulfonyl)benzoyl)guanidine Na+\/H+ antiporter inhibitors","volume":"40","author":"Baumgarth","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib209","unstructured":"R. Gerike, M. Baumgart, K.-O. Mink, N. Bajer, 4-sulfonyl Guanidine Derivatives, Method of Preparation and Pharmaceutical Composition, in, Merck Patent Gmbh, Russia."},{"key":"10.1016\/j.ejmech.2024.116170_bib210","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1161\/01.CIR.100.25.2519","article-title":"Inhibition of the Na+\/H+ exchanger confers greater cardioprotection against 90 minutes of myocardial ischemia than ischemic preconditioning in dogs","volume":"100","author":"Gumina","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ejmech.2024.116170_bib211","unstructured":"B. Erich, E. Christian, R. Otto, Novel Benzoyl Guanidine Derivatives, Process for Their Preparation and Their Use in the Preparation of Medicines, in, Boehringer Ingelheim Pharma KG, Germany."},{"key":"10.1016\/j.ejmech.2024.116170_bib212","doi-asserted-by":"crossref","first-page":"7114","DOI":"10.1021\/jm300601d","article-title":"Identification of a potent sodium hydrogen exchanger isoform 1 (NHE1) inhibitor with a suitable profile for chronic dosing and demonstrated cardioprotective effects in a preclinical model of myocardial infarction in the rat","volume":"55","author":"Huber","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib213","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0960-894X(01)00059-2","article-title":"Discovery of zoniporide: a potent and selective sodium\u2013hydrogen exchanger type 1 (NHE-1) inhibitor with high aqueous solubility","volume":"11","author":"Guzman-Perez","year":"2001","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2024.116170_bib214","unstructured":"W.G. Chen, E.D. Cox, A. Guzman-Perez, Sodium-hydrogen exchanger type 1tnhibitor (NHE-1), in, Pfizer Products Inc., Chen WG, Cox ED, Guzman-Perez A, United States."},{"key":"10.1016\/j.ejmech.2024.116170_bib215","doi-asserted-by":"crossref","first-page":"519","DOI":"10.5507\/bp.2015.060","article-title":"A minireview on NHE1 inhibitors. A rediscovered hope in oncohematology","volume":"159","author":"Mihaila","year":"2015","journal-title":"Biomed. Pap."},{"key":"10.1016\/j.ejmech.2024.116170_bib216","doi-asserted-by":"crossref","first-page":"326","DOI":"10.6023\/cjoc1108051","article-title":"Synthesis and Na+\/H+ exchanger-1-inhibitory activity of 4(6)-{2- 4-(2,3,4-trimethoxybenzyl)piperazin-1-yl -2-oxoethoxy}aroylguan idine derivatives","volume":"32","author":"Jin","year":"2012","journal-title":"Chin. J. Org. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib217","first-page":"2142","article-title":"Synthesis and Na+\/H+ exchanger 1 inhibitory activity of 4- 4-(2,3,4-trimethoxy-benzyl)-piperazin-1-ylmethyl benzoylguanidine derivatives","volume":"28","author":"Jiang","year":"2008","journal-title":"Chin. J. Org. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib218","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1016\/j.ejmech.2011.06.011","article-title":"Synthesis and Na+\/H+ exchanger inhibitory activity of benzoylguanidine derivatives","volume":"46","author":"Jin","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib219","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/cjoc.201180470","article-title":"Synthesis and bioactivity of substituted benzoylguanidine derivatives as potent Na+\/H+ exchanger inhibitors","volume":"30","author":"Jin","year":"2012","journal-title":"Chin. J. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib220","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1248\/cpb.45.1282","article-title":"Structural requirements for potent Na+\/H+ exchange inhibitors obtained from quantitative structure-activity relationships of monocyclic and bicyclic aroylguanidines","volume":"45","author":"Yamamoto","year":"1997","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2024.116170_bib221","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1248\/cpb.45.1975","article-title":"Design, synthesis and quantitative structure-activity relationship study of N-(3-oxo-3, 4-dihydro-2H-benzo[1, 4]oxazine-7-carbonyl)guanidine derivatives as potent Na+\/H+ exchange inhibitors","volume":"45","author":"Yamamoto","year":"1997","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2024.116170_bib222","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1248\/cpb.47.22","article-title":"An acid-catalyzed O, N-acyl migration and application to the synthesis of N-(4-isopropyl-2, 2-dimethyl-3-oxo-3, 4-dihydro-2H-benzo[1, 4]oxazine-6-carbonyl) guanidine methanesulfonate (KB-R9032), a novel Na+\/H+ exchange inhibitor","volume":"47","author":"Yamamoto","year":"1999","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2024.116170_bib223","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1016\/j.bmcl.2005.04.046","article-title":"4-Substituted (benzo[b]thiophene-2-carbonyl)guanidines as novel Na+\/H+ exchanger isoform-1 (NHE-1) inhibitors","volume":"15","author":"Lee","year":"2005","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2024.116170_bib224","unstructured":"J. Fujiwara, H. Mori, H. Yamashita, T. Kitamori, J. Hosoya, H. Banno, Quinoline-4-carbonylguanidine Derivatives, Process for Producing the Same and Pharmaceutical Preparations Containing the Compounds, in, Mitsui Toatsu Chemicals, Inc, United States."},{"key":"10.1016\/j.ejmech.2024.116170_bib225","unstructured":"A. Kojima, M. Kitano, A. Miyagishi, T. Noguchi, Y.H.S.I. Dekijim, N.K.S.I. Dek, N. Ohashi, Indoloylguanidine Derivatives as Inhibitors of Sodium-Hydrogen Exchange., in, Sumitomo Pharmaceuticals Company, Ltd, Europe."},{"key":"10.1016\/j.ejmech.2024.116170_bib226","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0014-2999(99)00645-7","article-title":"Cerebroprotective properties of SM-20220, a potent Na+\/H+ exchange inhibitor, in transient cerebral ischemia in rats","volume":"383","author":"Kuribayashi","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116170_bib227","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0014-2999(99)00283-6","article-title":"A Na+\u2013H+ exchange inhibitor (SM-20550) protects from microvascular deterioration and myocardial injury after reperfusion","volume":"374","author":"Ito","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116170_bib228","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1254\/jjp.84.196","article-title":"Effect of SMP-300, a new Na+\/H+ exchange inhibitor, on myocardial ischemia and experimental angina models in rats","volume":"84","author":"Yamamoto","year":"2000","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116170_bib229","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0014-2999(00)00613-0","article-title":"Cardioprotective effect of TY-12533, a novel Na+\/H+ exchange inhibitor, on ischemia\/reperfusion injury","volume":"404","author":"Aihara","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116170_bib230","unstructured":"A. Takahashi, K. Genkyou, S. Yoneyama, K. Aihara, T. Satoh, F. Yoneyama, J. Sasamori, S.-I. Yamada, T. Kimura, K. Kogi, Cycloalka[b]pyridine-3-carbonylguanidine Derivatives, Process for Producing the Same, and Drugs Containing the Same, in, Toa Eiyo Ltd., United States."},{"key":"10.1016\/j.ejmech.2024.116170_bib231","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1021\/jm010100v","article-title":"Arylcyclopropanecarboxyl guanidines as novel, potent, and selective inhibitors of the sodium hydrogen exchanger isoform-1","volume":"44","author":"Ahmad","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib232","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bmcl.2003.09.066","article-title":"Aminoimidazoles as bioisosteres of acylguanidines: novel, potent, selective and orally bioavailable inhibitors of the sodium hydrogen exchanger isoform-1","volume":"14","author":"Ahmad","year":"2004","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2024.116170_bib233","unstructured":"V.I. Petrov, A.A. Spasov, A.A. Ozerov, M.S. Novikov, N.A. Gurova, V.V. Gurova, Derivatives of quinazolin-4(3H)-one inhibiting sodium-hydrogen exchange, in, \u0413\u043e\u0441\u0443\u0434\u0430\u0440\u0441\u0442\u0432\u0435\u043d\u043d\u043e\u0435 \u0411\u044e\u0434\u0436\u0435\u0442\u043d\u043e\u0435 \u041e\u0431\u0440\u0430\u0437\u043e\u0432\u0430\u0442\u0435\u043b\u044c\u043d\u043e\u0435 \u0423\u0447\u0440\u0435\u0436\u0434\u0435\u043d\u0438\u0435 \u0412\u044b\u0441\u0448\u0435\u0433\u043e \u041f\u0440\u043e\u0444\u0435\u0441\u0441\u0438\u043e\u043d\u0430\u043b\u044c\u043d\u043e\u0433\u043e \u041e\u0431\u0440\u0430\u0437\u043e\u0432\u0430\u043d\u0438\u044f \"\u0412\u043e\u043b\u0433\u043e\u0433\u0440\u0430\u0434\u0441\u043a\u0438\u0439 \u0413\u043e\u0441\u0443\u0434\u0430\u0440\u0441\u0442\u0432\u0435\u043d\u043d\u044b\u0439 \u041c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u0438\u0439 \u0423\u043d\u0438\u0432\u0435\u0440\u0441\u0438\u0442\u0435\u0442\" Russia."},{"key":"10.1016\/j.ejmech.2024.116170_bib234","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-03722-w","article-title":"Synthesis and multifaceted pharmacological activity of novel quinazoline NHE-1 inhibitors","volume":"11","author":"Spasov","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2024.116170_bib235","unstructured":"G. Cremer, M. Daumas, M.-A. Adler, G. Dellac, V. Rouannet, C. Hoornaert, 4-[(1H-Imidazole-4-yl)piperidin-1-yl]anilide Derivatives, Their Preparation and Application in Therapy., in, Synthelabo, Cremer G, Daumas M, Adler M-A, Dellac G, Rouannet V, et al., (France)."},{"key":"10.1016\/j.ejmech.2024.116170_bib236","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/sj.bjp.0703671","article-title":"Pharmacological profile of SL-59.1227, a novel inhibitor of the sodium\/hydrogen exchanger","volume":"131","author":"Lorrain","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116170_bib237","doi-asserted-by":"crossref","first-page":"4796","DOI":"10.1016\/j.bmcl.2006.06.077","article-title":"Synthesis and biological activity of 5-aryl-4-(4-(5-methyl-1H-imidazole-4-yl)piperidin-1-yl)pyrimidine analogs as potent, highly selective, and orally bioavailable NHE-1 inhibitors","volume":"16","author":"Atwal","year":"2006","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2024.116170_bib238","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1021\/jm0104567","article-title":"Novel, non-acylguanidine-type Na+\/H+ exchanger inhibitors: synthesis and pharmacology of 5-tetrahydroquinolinylidene aminoguanidine derivatives","volume":"45","author":"Shoji","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib239","first-page":"358","article-title":"Synthesis and inhibitory effects on NHE1of [2-(5-substituted benzimidazol (or benzothiazol)-2-ylthio)-1-(4-substituted phenylethylidene)] aminoguanidines","volume":"17","author":"Yao","year":"2007","journal-title":"Chin. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib240","first-page":"1846","article-title":"Acute toxicity of storm water associated with de-icing\/anti-icing activities at Canadian airports","volume":"19","author":"Novak","year":"2000","journal-title":"Environ. Toxicol. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib241","first-page":"1375","article-title":"Toxicity of aircraft de-icer and anti-icer solutions to aquatic organisms","volume":"14","author":"Hartwell","year":"1995","journal-title":"Environ. Toxicol. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib242","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ejmech.2016.10.005","article-title":"Sodium hydrogen exchanger inhibitory activity of benzotriazole derivatives","volume":"126","author":"Singh","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib243","first-page":"341","article-title":"Rapid decrease of intracellular pH associated with inhibition of Na+\/H+ exchanger precedes apoptotic events in the MNK45 and MNK74 gastric cancer cell lines treated with 2-aminophenoxazine-3-one","volume":"25","author":"Nagata","year":"2011","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ejmech.2024.116170_bib244","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S0021-9258(19)40005-7","article-title":"The Na+-H+ exchanger of the placental brush-border membrane is pharmacologically distinct from that of the renal brush-border membrane","volume":"265","author":"Kulanthaivel","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2024.116170_bib245","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1038\/s41467-021-23496-z","article-title":"Structure and mechanism of the human NHE1-CHP1 complex","volume":"12","author":"Dong","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2024.116170_bib246","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1016\/j.celrep.2018.11.043","article-title":"Dual inhibition of the lactate transporters MCT1 and MCT4 Is synthetic lethal with metformin due to NAD+ depletion in cancer cells","volume":"25","author":"Benjamin","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejmech.2024.116170_bib247","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115707","article-title":"Discovery of indolinone-bearing benzenesulfonamides as new dual carbonic anhydrase and VEGFR-2 inhibitors possessing anticancer and pro-apoptotic properties","volume":"259","author":"Saied","year":"2023","journal-title":"Eur. J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424000503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424000503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T19:18:35Z","timestamp":1735067915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424000503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":247,"alternative-id":["S0223523424000503"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116170","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"pH regulators and their inhibitors in tumor microenvironment","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116170","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116170"}}